UNIVERSAL HEALTH SERVICES-B (UHS) Institutional Buying Activity
Institutional investors tracked by InsiderSet increased exposure to UNIVERSAL HEALTH SERVICES-B (UHS) during the quarter ended March 31, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.
The largest institutional buyer of UHS during the latest reporting period was Hancock Classic Value, which increased its reported UHS position by approximately $248.45M based on quarter-end filing values. Several additional hedge funds and long-term asset managers also reported meaningful increases in UHS exposure during the quarter.
Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward UNIVERSAL HEALTH SERVICES-B (UHS). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.
The investors highlighted on this page collectively added approximately $500.87M in reported UHS exposure during the latest filing period, reflecting continued institutional interest in UNIVERSAL HEALTH SERVICES-B's growth initiatives and strategic positioning.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2026 | First Eagle U.S. Value | Buy | 110,698 | 4,424,281 | $791,813,619 |
| Q4 2025 | Hancock Classic Value | Buy | 505,575 | 2,112,604 | $460,589,924 |
| Q4 2025 | Sequoia Financial Advisors | Buy | 266 | 4,650 | $1,013,780 |
| Q3 2025 | Hancock Classic Value | Buy | 1,215,286 | 1,607,029 | $328,541,009 |
| Q3 2025 | Sequoia Financial Advisors | Buy | 3,043 | 4,384 | $896,237 |
| Q3 2025 | First Eagle U.S. Value | Buy | 793 | 4,621,171 | $944,752,275 |
| Q1 2025 | First Eagle U.S. Value | Buy | 1,536 | 4,676,718 | $878,755,232 |
| Q4 2024 | First Eagle U.S. Value | Buy | 44,099 | 4,675,182 | $838,821,233 |
| Q3 2024 | Renaissance Technologies LLC | Buy | 50,600 | 148,100 | $33,916,381 |
| Q3 2024 | First Eagle U.S. Value | Buy | 4,039 | 4,631,083 | $1,060,564,366 |
| Q3 2024 | Torray Fund | Buy | 1,000 | 1,000 | $229,010 |
| Q2 2024 | Renaissance Technologies LLC | Buy | 55,400 | 97,500 | $18,030,675 |
| Q1 2024 | Hancock Classic Value | Buy | 132,942 | 455,773 | $83,160,342 |
| Q1 2024 | First Eagle U.S. Value | Buy | 6,451 | 4,636,880 | $846,045,178 |
| Q4 2023 | Hancock Classic Value | Buy | 322,831 | 322,831 | $49,212,358 |
| Q1 2023 | Olstein Capital Management | Buy | 2,000 | 30,000 | $3,813 |
| Q4 2022 | First Eagle U.S. Value | Buy | 101,132 | 4,733,178 | $666,857,448 |
| Q3 2022 | Olstein Capital Management | Buy | 109,000 | 163,000 | $6,572 |
| Q3 2022 | First Eagle U.S. Value | Buy | 28,511 | 4,632,046 | $408,454 |
| Q2 2022 | First Eagle U.S. Value | Buy | 448,046 | 4,603,535 | $463,622 |
| Q2 2022 | Olstein Capital Management | Buy | 20,000 | 54,000 | $5,438 |
| Q1 2022 | First Eagle U.S. Value | Buy | 56,358 | 4,155,489 | $602,338 |
| Q4 2021 | First Eagle U.S. Value | Buy | 502,100 | 4,099,131 | $531,493 |
| Q4 2021 | Olstein Capital Management | Buy | 11,000 | 48,000 | $6,224 |
| Q3 2021 | First Eagle U.S. Value | Buy | 546,643 | 3,597,031 | $497,721 |
| Q1 2021 | First Eagle U.S. Value | Buy | 48,466 | 3,066,328 | $409,017 |
| Q1 2021 | Renaissance Technologies LLC | Buy | 30,000 | 90,400 | $12,058 |
| Q3 2020 | First Eagle U.S. Value | Buy | 5,738 | 3,033,635 | $324,660 |
| Q2 2020 | First Eagle U.S. Value | Buy | 55,937 | 3,027,897 | $281,261 |
| Q2 2020 | Renaissance Technologies LLC | Buy | 54,900 | 246,900 | $22,935 |
Frequently asked questions about UHS activity
Which institutional owners are buying UHS?
Institutional owners buying UHS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in UHS activity?
"Buy" means an investor increased their reported position in UHS compared to the prior reporting period. This reflects growing exposure to UNIVERSAL HEALTH SERVICES-B (UHS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in UHS increasing?
Institutional interest in UHS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.